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Abstract: Surgiflo Haemostatic Matrix is an absorbable gelatin matrix hemostatic material that
has been widely used in various surgical operations to assist hemostasis. Nonetheless, as
biologically active agents (contains porcine gelatin), there is potential for allergic reactions to
these products. Here, we report the case of a 71-year-oldmanwho had intraoperative anaphylaxis
with cardiovascular events to gelatin associated with the use of a topical hemostatic agent
(Surgiflo). The patient reported a history of red meat allergy and tick bites during his allergolo-
gical examination after anaphylaxis. He also had high levels of specific IgE antibodies towards
alpha-gal. Special consideration should be given before administering bovine- or porcine-derived
gelatin products during surgery to patients with animal-related allergies, such as alpha-gal or
gelatin allergy and an atopic background.
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Introduction
The use of topical Hemostatic Matrix agents such as Gelfoam, FloSeal and SurgiFlo
in surgery is common and reduces bleeding during a wide variety of surgical
procedures.1 Such agents work by providing an environment for platelets to adhere
and aggregate within, thus building on the patient's natural coagulation cascade.
The patient's endogenous thrombin is activated, and the patient's thrombin converts
fibrinogen into an insoluble fibrin clot. The thrombin component of Hemostatic
matrix provides an ancillary effect to the innate hemostatic property of the flowable
gelatin matrix. When used in appropriate amounts, these hemostatic agents are
absorbed completely within 4–6 weeks.
Many of these new agents are combined with human thrombin and animal gelatins
(bovine and/or porcine gelatin matrix), which has potential for allergic reactions.
Gelatin is a denatured protein product made from boiled bovine or porcine hoofs,
horns and skin.2 The use of this kind of materials must be avoided in patients with
known allergies to gelatin. Here, we would like to report a case of an intraoperative
anaphylactic reaction to Surgiflo (Hemostatic Matrix; Ethicon Inc, Somerville, NJ,
USA), a hemostatic agent containing partially reconstituted porcine gelatin used to
decrease surgical bleeding. To our best knowledge, this is the first reported case with
intraoperative anaphylaxis secondary to a gelatin allergy observed in Norway.
Case report
A 71-year-old male residing in Bergen, western coast of Norway, was referred to our
department (Section for Clinical Allergology, Department of Occupational Diseases)
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because of suspected anaphylaxis secondary to Surgiflo dur-
ing a surgical operation. He has had chronic obstructive pul-
monary disease (COPD) since 2004 and received a diagnosis
of Atrial Septal Defect (ASD) later on. He was operated for
ASD in October 2017. During the operation, anesthesia was
induced with midazolam hydrochloride, fentanyl citrate, thio-
pental natrium and vecuronium bromide without any compli-
cations. The Surgiflo (Human thrombin with porcine
hemostatic matrix) was used in the last phase of the operation.
The patient had at that timepoint been released from the
cardiopulmonary bypass, and SAGMAN blood product,
thrombocytes and protamine sulfate had been given, and con-
trol of hemostasis confirmed. Shortly after the Surgiflo was
placed over the sutures on the outside of the right atrium,
hemodynamic instability suddenly occurred.Within 2–3mins,
he experienced rapid onset of hypotension, tachycardia and
high airway pressure. The patient was given a bolus-injection
10 mg of ephedrine in the initial phase of the reaction, and
then continuous infusion of epinephrine and norepinephrine,
initially at rate 0.2 µg/kg/min and 0.7 µg/kg/min, respectively.
A bolus dose of epinephrine 0.04 mg was also given.
Approximately after 60 mins, the infusion rate of epinephrine
and norepinephrine was reduced to 0.1 µg/kg/min. Also,
hydrocortisone 200 mg i.v. and dexchlorpheniramine 5 mg
i.v were given. After a while, his vital signs became stable,
and surgery was completed successfully. It was also noted that
he had erythematous rash on his trunk. Thereafter, he was
referred to us for allergological examination against Human
Hemostatic Matrix, Surgiflo.
According to atopic background, he had no known
history of allergic disease personally or in his first degree
relatives. However, he has stated that he could not eat
meat when he was between 9 and 19 years old. Three to
four hours after intake of meat, he experienced allergic
reaction with itching and observed afterwards urticaria on
the whole body, especially arms and abdomen, and thick
feeling in the throat with moderate dyspnea, but no dizzi-
ness, nausea or diarrhea. The patient reported that he was
bitten by ticks in a local forest when he was on a trip at the
age of 8 years, and a reaction against meat came after this
episode. He had no any tick bites since then. Interestingly,
this allergic reaction after intake of meat disappeared
around the age of 19 years. Currently, the patient may
consume meat and meat products without any problems.
We performed allergological examination at our
department. Skin prick test with Surgiflo, latex, chlorhex-
idine, midazolam hydrochloride, fentanyl citrate, thiopen-
tal natrium and vecuronium bromide were negative, and
skin prick test using a standard food allergen panel with
six allergens (egg white, cow’s milk, codfish, wheat flour,
peanut and soy) including raw ox, pork and sheep meat
were also negative. However, skin prick test with gelatin
was positive. Blood samples for specific IgE against ox,
pork and lamb were high (sIgE: 3.28; 1.40 and 0.47,
respectively; and upper normal limit of sIgE for these are
<0.35 kU/L). Moreover, the IgE antibodies specific for
alpha-1,3-galactose (alpha-gal) were high (sIgE: 26.6 kU/
L). Otherwise, routine blood tests and other allergy para-
meters in serum such as specific IgE against gelatin, latex,
chlorhexidine, standard food allergy panel with six aller-
gens (egg white, cow’s milk, codfish, wheat flour, peanut
and soy), standard airway panel with eight allergens
(birch, timothy, mugwort, Dermatophagoides pteronyssi-
nus, Cladosporium herbarum, cat, dog, and horse) (ALK
Abello, Hørsholm, Denmark), and tryptase were within the
normal reference range except serum total IgE level was
slightly high (153 kU/L). Furthermore, histamine release
test (HRT) and basophil activation test (BAT) were con-
ducted to further elucidate the clinical history. HRT was
performed according to the producer’s protocol (Reflab
ApS, Copenhagen, Denmark), with small adjustments.
HRT was done twice, first with Surgiflo, then two months
later with lamb, beef and pork. In short, the allergen is
titrated in an 11 step serial dilution in PIPES puffer. PIPES
buffer is used as negative stimuli and anti-IgE is used as a
positive control. After the controls and samples are incu-
bated with the patient’s blood, the samples are washed,
dried and shipped to Reflab in Denmark for histamine
measurement. Our in-house BAT is based on incubating
a suspected allergen with the patient’s heparinized whole
blood. BAT was also performed twice, first with Surgiflo,
then three months later with Surgiflo and alpha-gal-HSA
(Bühlmann Laboratories AG, Scönenbuch, Switzerland).
The allergens are dissolved in phosphate-buffered saline
(PBS; Sigma Aldrich Norway AS, Oslo, Norway) and
using in six 10-fold dilutions in PBS. PBS is also used
as a negative control, while anti-FcεR1 (Bühlmann
Laboratories AG) provides a positive control.
Immediately after the stimuli is added, the cells are stained
with a titrated mix of anti-CD63 FITC (Beckman Coulter,
Brea, CA, USA), anti-CD123 APC (Miltenyi Biotec,
Bergisch Gladbach, Germany), anti-CD193 BV421
(Biolegend, San Diego, CA, USA) and anti-CD203c PE
(Beckman Coulter). After 25-min incubation at 37°C, the
samples are RBC-lyzed (Agilent Technologies ApS,
Glostrup, Denmark), washed (CellWash; BD Biosciences,
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Franklin Lakes, NJ, USA) and analyzed on a Canto II flow
cytometer (BD Biosciences). Basophils are identified as
SSClow, CD193high, and CD123+ events and 250 baso-
phils are collected in each sample. Basophil activation is
evaluated by setting a gate at 3% CD63+ and CD203c+ in
basophils with negative stimulus. The FcεR1-stimulated
basophils must reach ≥16%, in both CD63 and CD203c
in order for the test to be accepted. If either CD63 or
CD203c is <16%, the test is rejected as inconclusive. A
sample is considered positive if either CD63 and/or
CD203c reach ≥16% positive basophils in one or more
dilutions of the allergen. Unfortunately, neither HRT nor
BAT yielded a positive test result. RefLab interpreted all
allergen stimulations negative. Also, the allergens could
not induce basophil activation in either of the BATs. At the
both times, anti-FcεR1 failed to stimulate the patient’s
basophils (CD63; 6.4% and 6.8%, CD203c; 6.0% and
2.4%). Therefore, the patient was concluded to be a non-
responder.
The patient had alpha-gal allergy induced by tick bites.
He had anaphylaxis during surgery after receiving
Surgiflo, which contains gelatin from pigs. This reaction
could be explained by his high levels of alpha-gal specific
IgE antibodies, a carbohydrate that could be present in the
porcine-derived gelatin that Surgiflo is based on. He was
recommended avoiding exposure to products derived from
bovine or porcine gelatin in future operations. The patient
provided written informed consent prior to the publication
of this case report.
Institutional approval was also obtained to publish the
case details.
Discussion
To our best knowledge, this is the first published case to
report an intraoperative anaphylaxis secondary to gelatin
allergy which has been observed in our country. Even
though this is an unusual allergic reaction, intraoperative
anaphylaxis against hemostatic agents has been
described in few similar cases from other countries in
the literature.3–6
In general, intraoperative anaphylactic reactions are
rare, with an estimated incidence of 1:4,000 to 1:25,000.
Previously, an anaphylactic reaction to Surgiflo, a hemo-
static agent containing partially reconstituted porcine gela-
tin used to decrease surgical bleeding, has been reported to
cause anaphylaxis with sudden and profound hypotension
during posterior spinal fusion in an adolescent with a
history of repaired truncus arteriosus.7 Anaphylactic
reaction to gelatin-containing hemostatic agents have also
been reported in the ophthalmic and orthopedic literature,
most commonly during scoliosis repair in adolescents.2,8
Intraoperative anaphylaxis was observed after intraosseous
gelatin administration.8
Allergic reaction to gelatin may be immune or non-
immune mediated reactions. Immune allergic reactions can
be mediated by immunoglobulin E (IgE) or non-IgE
mediated.
IgE-mediated (type 1) reactions can be detected with in
vitro immunoglobulin testing. Gelatins are high-molecu-
lar-weight peptides derived from various animal collagens
and are used in several foods, medications, cosmetics and
vaccines as stabilizers. Gelatin comes from different
sources and has different degrees of allergenicity depend-
ing on type of gelatin, its processing, molecular weight,
melting point and dosage. Gelatin allergy has been well
described in reactions to gummy candy and vaccines, such
as measles, mumps and rubella containing gelatin as a
stabilizer.9 However, there are few publications on its
impact in intraoperative anaphylaxis, particularly as a
component of surgical hemostatic agents.
The alpha-Gal syndrome is triggered by IgE antibody
response against the carbohydrate Galactose-alpha-1,3-
galactose, which is present in glycoproteins from tick saliva
and tissues of non-catarrhine mammals. The association
between tick bites and the development of mammalian
meat allergy was first described in 2007 by van Nunen
et al. Later, this association was confirmed in 2009 by
Commins et al, and they discovered the epitope likely
responsible for such allergic reactions (α-Gal).10 The
alpha-Gal syndrome is a regionally common form of food
allergy that has a characteristic with delay in symptom onset
and can develop at any time in life.11 It has been suggested
that tick bites inoculate also other antigens such as gelatin
that could potentially sensitize the patient.12 When the
patients avoid successfully further tick bites and red meat,
the circulating alpha-gal-specific IgE antibody concentra-
tions diminished over time, as previously observed.12
Our patient developed sudden and profound hypoten-
sion after receiving Surgiflo. Given that the patient’s
symptoms were classic for anaphylaxis and that the timing
of the anaphylaxis immediately followed the administra-
tion of SurgiFlo, we believe that SurgiFlo was the cause of
the reactions. Additional allergological examination
obtaining detailed medical history (red meat allergy
induced by tick bites), positive skin prick test with gelatin,
high serum levels of alpha-gal and its relation with gelatin
Dovepress Lied et al
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allergy help support the diagnosis. This patient reminds us
of the importance of eliciting a thorough allergy history
prior to beginning new therapies. Special care should be
taken in the administration of these products, particularly
in the atopic individuals, particularly in patients who have
a history of gelatin and/or alpha-gal allergy.
A study from Mullins RJ et al showed that there is a
relationship between red meat allergy and sensitization to
gelatin and galactose-alpha-1,3-galactose (alpha-gal).13
They have investigated the clinical significance of gelatin
sensitization, the predictive value of a positive test and an
examination of the relationship between allergic reactions
to red meat and sensitization to gelatin and alpha-gal. The
results showed that there was a strong significant correla-
tion between positive gelatin skin tests and serum specific
IgE levels of alpha-gal in the patients serum. Furthermore,
alpha-gal was detected in bovine gelatin colloids by inhi-
bition radioimmunoassay. They also found asymptomatic
sensitization to gelatin, red meat and alpha-gal in a small
number of patients with tick bite reactions in another
country with different tick species. Overall, they have
identified a significant relationship between adult onset
red meat allergy and sensitization and clinical reactivity
to gelatin. Most patients allergic to red meat were also
sensitized to gelatin and a subset was clinically allergic to
both. The detection of alpha-gal in gelatin and correlation
between the results of alpha-gal and gelatin testing raises
the possibility that alpha-gal specific IgE may be the
reason for reactivity to gelatin. In our patient, we also
found positive skin prick test with gelatin and high level
of specific IgE toward alpha-gal in patient’s serum in
accordance with literature. Thus, meat allergy could repre-
sent a risk factor for gelatin allergy.
Conclusion
Prior reactions to gelatin, bovine or porcine products, includ-
ing immunizations, gelatin, meat allergy (alpha-gal) and
gummy candy should be considered a contraindication to the
use of gelatin containing hemostatic agents during surgery. In
preoperative screening, high serum specific IgE levels of
alpha-gal might have a high positive predictive value on
possible reactions to hemostatic matrix agents. Therefore, it
can be useful to screen for alpha-gal specific IgE antibodies in
patients who present an atopic background andmedical history
of tick-induced red meat allergy in order to minimize the
likelihood of intraoperative cardiovascular events to hemo-
static matrix agents.
Disclosure
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